[PDF][PDF] Human biodistribution, dosimetry and clinical use of technetium (III)-99m-Q12

C Rossetti, G Vanoli, G Paganelli… - Journal of Nuclear …, 1994 - Soc Nuclear Med
(2.2% Injecteddoseat 1 hr postinjectionunderrestingcondi tions) and no detectable
myocard@ washout or redistributionup to 5 hr posbnjec@ on. The t@ OdiStdbUtIOnis …

[PDF][PDF] Myocardial uptake and kinetic properties of technetium-99m-Q3 in dogs

MC Gerson, RW Millard, AJ McGoron… - Journal of Nuclear …, 1994 - Soc Nuclear Med
99rnTcactMty &) was related to myocard@ I blood flow (x) from 0 to 6.1 mI/min/gby the
relationshipy= 0.83 X+ 0.18, r= 0.95, p= 0.0001. The ScmntigraphiCra@ oof …

Review on 99mTc radiopharmaceuticals with emphasis on new advancements

A Duatti - Nuclear Medicine and Biology, 2021 - Elsevier
Rapid imaging acquisition, high spatial resolution and sensitivity, powered by
advancements in solid-state detector technology, are significantly changing the perspective …

Kinetic properties of 99mTc-Q12 in canine myocardium.

MC Gerson, RW Millard, NJ Roszell, AJ McGoron… - Circulation, 1994 - Am Heart Assoc
BACKGROUND 99mTc-Q12 is a new Tc (III) perfusion imaging agent that permits prompt
myocardial visualization in humans. We postulated that 99mTc-Q12 myocardial activity is …

[PDF][PDF] Myocardial clearance kinetics of technetium-99m-SQ30217: a marker of regional myocardial blood flow

RE Stewart, M Schwaiger, GD Hutchins… - Journal of Nuclear …, 1990 - Soc Nuclear Med
METHODS Open-Chested Heart Preparation Ten mongrel dogs of both sexes weighing
12— 25kg were anesthetized with iv pentobarbital (30 mg/kg). Each dog was intubated and …

Unparalleled contribution of technetium-99m to medicine over 5 decades

WC Eckelman - JACC: Cardiovascular Imaging, 2009 - jacc.org
Since the first tracer study by George C. de Hevesy in 1923, in which he used the tracer
principle to study the absorption and translocation of lead nitrate with Pb-212 (1) …

[PDF][PDF] Technetium-99m hexakis 2-methoxyisobutyl isonitrile: human biodistribution, dosimetry, safety, and preliminary comparison to thallium-201 for myocardial …

J Frans, DS Berman, J Maddahi… - Journal of Nuclear …, 1989 - Soc Nuclear Med
Technetium-9 9m Hexakis 2-Methoxyisobutyl Isonitrile:Human Biodistribution, Dosimetry,
Safety, and Preliminary Comparison to Tha Page 1 echnetium-99m hexakis-2-methoxyisobutyl …

[PDF][PDF] Measurement of myocardial blood flow using a co-injection technique for technetium-99m-teboroxime, technetium-96-sestamibi and thallium-201

RJ Di Rocco, WL Rumsey, BL Kuczynski… - Journal of Nuclear …, 1992 - Soc Nuclear Med
Radiopharmaceutical Preparation Technetium-99m-teboroxime was prepared as previously
de scribed (11). Thallium-201 was obtained from Dupont. The@ Tc was produced by …

99mTc-N-NOET imaging for myocardial perfusion: can it offer more than we already have?

D Fagret, C Ghezzi, G Vanzetto - Journal of Nuclear Medicine, 2001 - Soc Nuclear Med
Aneutral, lipophilic 99mTc-labeled compound proposed as a myocardial perfusion imaging
agent is 99mTc-(N-ethoxy-N-ethyl-dithiocarbamato) nitrido (N-NOET)(1). 99mTc-N-NOET …

99mTc-N-DBODC5, a new myocardial perfusion imaging agent with rapid liver clearance: comparison with 99mTc-sestamibi and 99mTc-tetrofosmin in rats

K Hatada, LM Riou, M Ruiz, Y Yamamichi… - Journal of Nuclear …, 2004 - Soc Nuclear Med
99mTc-[bis (dimethoxypropylphosphinoethyl)-ethoxyethylamine (PNP5)]-[bis (N-ethoxyethyl)-
dithiocarbamato (DBODC)] nitride (N-PNP5-DBODC or N-DBODC5) is a new monocationic …